Associate Director, Obesity Health Equity

at  Novo Nordisk

Associate Director, Obesity Health Equity
Category: Project Management & Agile
Location:Bagsværd, Capital Region of Denmark, DK
Are you passionate about health equity? Can you make a difference by designing access and affordability strategies and solutions for a leading healthcare company? Are you ready to play a key role in ensuring that social responsibility is embedded throughout Novo Nordisk’s work in obesity?
If so, this is your chance as we are looking for an Associate Director to join our Obesity Health Equity team.
Start your application for a life-changing career!

QUALIFICATIONS

• A master’s degree in business administration, health economics, or public health.
• Solid understanding and experience of market access and affordability strategies in the healthcare industry
• Proven project management leadership skills
• Ability to develop new business models and solutions to address strategic problems, with a focus on strategy execution.
• Global project management and stakeholder management experience.
  As a person, you are driven by a passion for health equity, possessing strong stakeholder management skills to collaborate with external partners and expert organizations. Your expertise in market access and affordability, coupled with a solid understanding of building equity, enables you to establish new business models and lead strategic initiatives to address access and affordability challenges.

• Lead the implementation of the access and affordability components of Novo Nordisk’s social responsibility work in obesity, including collaborating with internal stakeholders to embed and advance equity considerations in cross-functional agendas.
• Ensure operational excellence in the implementation of the access and affordability components of Novo Nordisk’s social responsibility work in obesity across the organization, including support to affiliates.
• Develop and maintain partnerships with external stakeholders, including representing Novo Nordisk on a global scale.
• Establish Novo Nordisk as a corporate leader in addressing access and affordability issues related to obesity